Take Homes in IBD

Take Homes in IBD

Source: Afzali A. Choosing Precision Therapy for IBD. Presented at: ACG/FGS Spring Symposium; March 11-13, 2022; Naples, Florida.
Disclosures: Afzali reports financial relationships with AbbVie, Bristol Myers Squibb, DiaSorin, IBD Horizons, Janssen, Lilly, Pfizer, Takeda and TLL Pharma and serving on the speaker’s bureau for AbbVie, Bristol Myers Squibb, Janssen, Pfizer and Takeda.
March 25, 2022
1 min watch
Save

VIDEO: The importance of individualized care in IBD

Source: Afzali A. Choosing Precision Therapy for IBD. Presented at: ACG/FGS Spring Symposium; March 11-13, 2022; Naples, Florida.
Disclosures: Afzali reports financial relationships with AbbVie, Bristol Myers Squibb, DiaSorin, IBD Horizons, Janssen, Lilly, Pfizer, Takeda and TLL Pharma and serving on the speaker’s bureau for AbbVie, Bristol Myers Squibb, Janssen, Pfizer and Takeda.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NAPLES, Florida — In this video, Anita Afzali, MD, MPH, FACG, discusses key takeaways from her presentation on precision therapy in IBD at the 2022 ACG/FGS Spring Symposium.

“What I really want to highlight is the importance of practicing individualized, personalized therapy in [IBD],” Afzali, a gastroenterologist and medical director of the Inflammatory Bowel Disease Center at The Ohio State University, told Healio. “So, we first start with recognizing that there are different prognostic factors for each of our individual patients. That’s how we can best choose precision, and that’s how we best choose the appropriate therapy for, perhaps, an aggressive phenotype.”

In discussing how clinicians can proactively monitor IBD with a range of therapies, Afzali emphasized the importance of “making sure that we’re appropriately monitoring the disease to determine whether the treatment — regardless of what the treatment is — is working for each of our individual patients.”